公司資料
Veeva 股價、新聞與催化劑
- 股票代碼:
- VEEV
- 交易所:
- NYSE
- 產業:
- Biopharma
- 所在地:
- United States
股票表現
238.34 USD (-2.22%)
收盤價
最後更新: 2026年8月17日
29.9B USD
市值
股價為何變動
As of Aug 17, 2026, VEEV closed down 2.22% at $238.34. No new same-company headline was identified in the current news window.
公司概覽
業務概覽
Veeva Systems is a cloud software company built specifically for the life sciences industry. Its core products support commercial, clinical, regulatory, and data workflows for pharma and biotech customers, making it a key infrastructure name rather than a therapeutic developer.
所在地與產業分類
Headquartered in the United States and listed on NYSE, Veeva has a global footprint across life sciences companies. It sits in enterprise software and life sciences technology, not biotechnology proper.
商業模式特徵
The business relies on recurring software subscriptions, customer retention, and cross-sell across commercial and development workflows. Investors tend to watch subscription growth, operating margin, product expansion, and the strength of the broader life sciences spending environment.
生技產業定位
Veeva is one of the most important software platforms in the biotech ecosystem. It is not a drug stock, but it matters because it helps power commercial and clinical operations across the sector.
未來催化劑
- Veeva’s catalysts are Vault CRM adoption, clinical-data-cloud traction, and continued penetration of regulated-life-science software. That readout matters because it decides whether the asset is ready for a larger and more expensive development step. If the data come in cleanly, the market tends to give the broader platform behind the program more credit.
近期新聞
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。